With your support, we have been able to fund outstanding research, leading toward cures and improved quality of life for children with cancer. Browse through more than 1,000 funded projects below.
Use the search tool to refine your results. You can also click on a heading to sort by project title, institution name, or year the grant was awarded. Click on the project title to read more information.
You can learn about ALSF's grant review process here.
ALSF Funded Research Projects
|Project Title||Institution / Principal Investigator(s)||Grant Type||Year||State|
|Identifying Drug Resistant Mutations in Ph-like Acute Lymphoblastic Leukemia||University of California San Francisco / Mignon Loh, M.D.||Innovation Grants||2014||California|
|Single-Cell Profiling of Acute Myeloid Leukemia for High-Resolution Chemo-immunotherapy Target Discovery||Stanford University School of Medicine / Charles Gawad, MD/PhD||Single-cell Pediatric Cancer Atlas Grant||2019||California|
|Studying the clonal dynamics and evolution of leukemia using molecular barcodes||Lucile Packard Children's Hospital at Stanford University School of Medicine / Matthew Porteus, MD, PhD||Innovation Grants||2011||California|
|Preclinical Testing of Candidate Therapeutics in a Pediatric Spinal Cord High-grade Glioma Model||Stanford University / Michelle Monje, MD/PhD||Innovation Grants||2016||California|
|In-vivo characterization of MYCN-driven immunosuppression||University of California San Francisco / William Weiss, MD/PhD||Innovation Grants||2021||California|
|Antibody Targeted Natural Killer Cell-Derived Extracellular Vesicles for the Treatment of Childhood Acute Lymphoblastic Leukemia and Neuroblastoma||Children's Hospital Los Angeles / Robert Seeger, MD & Alan Wayne, MD||Innovation Grants||2015||California|
|Identifying novel biomarkers for risk stratification in t-cell acute lymphoblastic leukemia (ALL).||University of California San Francisco / Michelle Hermiston, MD, PhD||Young Investigator Grants||2009||California|
|Predicting Outcome and Ameliorating Toxicities of the Immunotherapy of Neuroblastoma||University of California, San Diego / Alice Yu, MD, PhD||Innovation Grants||2011||California|
|Enhancing TKI Therapy in Ph-Like Leukemia||The Regents of the University of California, Irvine / David Fruman, PhD||Reach Grants||2022||California|
|Circulating Repetitive Element RNAs as an Osteosarcoma Marker||Children's Hospital Los Angeles / David Cobrinik, MD/PhD||Innovation Grants||2018||California|